🔎 Trials Near Me

Beranda › Kanker Payudara › Iowa › Cedar Rapids

Uji klinis Kanker Payudara di Cedar Rapids, IA

17 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Cedar Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Menerima pesertaFase 1/2
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06324357

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Local Institution - 0065, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06618287

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Menerima pesertaFase 3
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07174336

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Menerima pesertaFase 1
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06756932

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07029399

Exercise Oncology Clinic Pilot Feasibility Trial

Menerima peserta
  • University of Iowa Health Care, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07765927

Breast Cancer PSMA PET

Menerima pesertaFase awal 1
  • University of Iowa Healthcare, Iowa City · 25 mi jauhnya
Usia 18 hingga 90 · Wanita · Diperbarui 6 Agu 2026 · NCT06586047

E-Mindfulness Approaches for Living After Breast Cancer

Menerima pesertaFase 3
  • Saint Luke's Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Menerima pesertaFase 4
  • Iowa Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06169371

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Menerima pesertaFase 1
  • University of Iowa Health Care, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05283330

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • Saint Luke's Hospital, Cedar Rapids
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

Quantitative MRI Assessment of Breast Cancer Therapy Response

Menerima pesertaStudi observasional
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT05704062

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Iowa City · 25 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Payudara di kota lain

Studi lain di Cedar Rapids

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.